Yale Once-Monthly Obesity Medication Is A Potential Treatment for Weight Loss For millions living with obesity and type 2 diabetes, medication adherence can be a constant struggle. Now, new research points to a future where a single monthly injection could replace the current w... clinical trials GLP-1 medications MariTide obesity pharmaceuticals type 2 diabetes weight loss Yale research
How NVIDIA, AWS, IonQ and AstraZeneca Are Using Quantum Computing to Revolutionize Drug Discovery Drug discovery has long been defined by painstaking research and drawn-out timelines. Now, a partnership between IonQ , AstraZeneca , AWS , and NVIDIA is reimagining what’s possible in pharmaceutical ... AWS computational chemistry drug development hybrid workflows IonQ NVIDIA pharmaceuticals quantum computing
FDA’s Shift Away from Animal Testing: A New Era in Drug Development The pharmaceutical landscape is on the verge of a significant transformation as the FDA embarks on a journey to phase out animal testing in favor of innovative, human-relevant alternatives. This strat... animal testing biotechnology clinical trials drug development FDA organ chips pharmaceuticals
Revolutionizing Drug Discovery with Multifidelity Bayesian Optimization Pushing the Boundaries of Automated Drug Discovery The landscape of drug discovery is rapidly evolving as automation and advanced algorithms take center stage. Multifidelity Bayesian optimization (MF-... automation Bayesian optimization drug discovery experimental design machine learning pharmaceuticals robotics
How OpenAI and the FDA Could Transform Drug Approval With AI A New Era for Drug Evaluation Is Emerging Imagine a future where patients no longer wait years for innovative treatments to become available. That vision is closer to reality as OpenAI and the FDA exp... AI drug approval FDA healthcare technology OpenAI pharmaceuticals regulation